ECM
TXG icon

Evergreen Capital Management’s 10x Genomics TXG Stock Holding History

Evergreen Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Sell
10,450
-3,316
-24% -$86.9K 0.01% 1036
2026
Q1 		$292K Sell
13,766
-991
-7% -$19.8K 0.01% 1140
2025
Q4 		$241K Buy
+14,757
New +$223K 0.01% 1190
2025
Q2 		– Sell
-10,850
Closed -$94.7K – 1255
2025
Q1 		$94.7K Buy
+10,850
New +$137K ﹤0.01% 1068
2021
Q2 		– Sell
-1,206
Closed -$218K – 555
2021
Q1 		$218K Buy
+1,206
New +$208K 0.01% 463

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evergreen Capital Management's TXG Position: Q2 2026 in Review

Evergreen Capital Management reduced its 10x Genomics (TXG) stake by 24% in Q2 2026, selling an estimated $86.9K and leaving 10,450 shares worth $401K. The position accounts for 0.01% of the portfolio, ranked #1036.

Evergreen Capital Management first reported a position in TXG in Q1 2021 and has held it in 5 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Evergreen Capital Management held 10,450 shares of 10x Genomics worth $401K as of Q2 2026.
  • Evergreen Capital Management sold 3,316 10x Genomics shares in Q2 2026, an estimated $86.9K.
  • 10x Genomics made up 0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #1036 holding.
  • Evergreen Capital Management first reported a position in 10x Genomics in Q1 2021 and has held it in 5 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.